David Kreutter

  • Former Vice President Business Analytics and Insights, Pfizer

David Kreutter is an executive with 30 years of experience in the pharmaceutical industry at Pfizer. His roles have included R&D, decision analysis and strategic portfolio management, commercial operations and global business analytics.  He has a proven track record in forming and leading high-performing teams, and leading large-scale innovation in strategy, analytics and operations.  He is a sought-after speaker on the topics of creating a data-driven culture, and driving transformation and competitive advantage through analytics.

David founded and led the Portfolio and Decision Analysis Group, which was awarded the Raiffa-Howard Award in 2016 for Organizational Decision Quality.  Under the sponsorship of the CEO and the Scientific Advisory Committee of the Board of Directors, David led the development of a global therapeutic area strategy that aligned the R&D, Medical, and Commercial divisions on the areas of focus for internal pursuit and for licensing activities.  He led the prioritization of the development portfolio that was also used as the framework for in-licensing decisions. 

David led a large US commercial model innovation focused on enhancing customer centricity through digital and analytics technologies. He also led the formation of a mixed insourced/outsourced global analytics operating model with an advanced analytics COE and regional delivery hubs.  David recently led a broad industry/academia collaboration with IBM, Partners Healthcare and the Broad Institute focused on using EMR and big data to understand disease risk and progression to enable a vision of precision medicine. 

David is currently leveraging his expertise and experience by providing strategy consulting services to the life sciences industry, and advisory services to life sciences start-up companies. David is an executive advisor to PwC and to IQVIA, focusing on organizational transformation. He is on the bioinformatics advisory board for NYU Tandon School of Engineering, is an advisor to Rxvantage, Rimedio and is a director for nQ Medical.  David is sharing his leadership experience in analytics and his personal lessons on what is required to create a data-driven culture by teaching the next generation of analytics leaders. He is adjunct faculty in the MS in Applied Analytics program at Columbia University.